Abstract
Inherited cerebellar ataxias (CA) are heterogeneous progressive neurological conditions associated with significant functional limitations. This study aimed to assess the implications of inherited CA on patients’ self-reported quality of life (QoL) and impairments in work and activities. 129 individuals with ataxia responded to a survey focused on QoL. Health-related QoL was measured using the RAND 36-Item Short Form Survey. An adaptation of the validated Work Productivity and Activity Impairment questionnaire was used to assess the effect of health on work productivity and ability to perform activities over the past week. Nine percent of respondents were currently employed. Individuals with inherited ataxia experienced significant activity impairment, and 75% required professional or informal care. Health-related quality of life (HRQoL) was significantly worse in all areas for the individuals with inherited ataxia compared with Irish population normative values. Participants with Friedreich’s ataxia (n = 56) demonstrated worse physical functioning then those with undetermined ataxia (n = 55). Female gender, younger age at symptom onset, current employment, retirement due to age or ataxia, and living in a long-term care facility were associated with higher sub-scores in different domains of HRQoL, while disease duration correlated with worse physical functioning sub-scores. This study is the first cross-sectional study on HRQoL in patients with inherited ataxia in Ireland. It highlights high rates of unemployment, difficulty with daily activities and physical functioning limitations, which is worse than comparative international studies. Given the limited therapeutic options currently available, optimising HRQoL is an important aspect of managing ataxia.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Coarelli G, Wirth T, Tranchant C, Koenig M, Durr A, Anheim M. The inherited cerebellar ataxias: an update. J Neurol. 2023;270(1):208–22.
Vankan P. Prevalence gradients of Friedreich’s ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge. J Neurochem. 2013;126(Suppl 1):11–20.
Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3–8.
Rojas P, Ramírez AI, Hoz R, et al. Ocular involvement in friedreich ataxia patients and its relationship with neurological disability, a follow-up study. Diagnostics (Basel). 2020;10(2):75.
Schulz JB, Boesch S, Bürk K, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5(4):222–34.
Bürk K. Friedreich ataxia: current status and future prospects. Cerebellum Ataxias. 2017;4:4.
Hanson E, Sheldon M, Pacheco B, Alkubeysi M, Raizada V. Heart disease in Friedreich’s ataxia. World J Cardiol. 2019;11(1):1–12.
Cortese A, Simone R, Sullivan R, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649–58.
Bogdanova-Mihaylova P, Hebert J, Moran S, et al. Inherited cerebellar ataxias: 5-year experience of the Irish National Ataxia Clinic. Cerebellum. 2021;20(1):54–61.
Malaquias MJ, Braz L, Santos Silva C, et al. Multisystemic RFC1-related disorder: expanding the phenotype beyond cerebellar ataxia, neuropathy, and vestibular areflexia syndrome. Neurol Clin Pract. 2023;13(5):e200190.
World Health Organization, et al. Programme on mental health: WHOQOL user manual. (No. WHO/HIS/HSI Rev. 2012.03). Geneva, Switzerland: World Health Organization; 1998.
Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645–9.
Sánchez-López CR, Perestelo-Pérez L, Escobar A, López-Bastida J, Serrano-Aguilar P. Health-related quality of life in patients with spinocerebellar ataxia. Neurología (English Edition). 2017;32(3):143–51.
Tai G, Yiu EM, Corben LA, Delatycki MB. A longitudinal study of the Friedreich Ataxia Impact Scale. J Neurol Sci. 2015;352(1–2):53–7.
Paulsen EK, Friedman LS, Myers LM, Lynch DR. Health-related quality of life in children with Friedreich ataxia. Pediatr Neurol. 2010;42(5):335–7.
Delmont E, Hiew FL, Cassereau J, et al. Determinants of health-related quality of life in anti-MAG neuropathy: a cross-sectional multicentre European study. J Peripher Nerv Syst. 2017;22(1):27–33.
Reetz K, Dogan I, Hilgers RD, et al. Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Lancet Neurol. 2016;15(13):1346–54.
Johnson NE, Heatwole CR, Dilek N, et al. Quality-of-life in Charcot-Marie-Tooth disease: the patient’s perspective. Neuromuscul Disord. 2014;24(11):1018–23.
Félix E, Gimenes AC, Costa-Carvalho BT. Effects of inspiratory muscle training on lung volumes, respiratory muscle strength, and quality of life in patients with ataxia telangiectasia. Pediatr Pulmonol. 2014;49(3):238–44.
Brandsema JF, Stephens D, Hartley J, Yoon G. Intermediate-dose idebenone and quality of life in Friedreich ataxia. Pediatr Neurol. 2010;42(5):338–42.
Yap KH, Azmin S, CheHamzah J, Ahmad N, van de Warrenburg B, Mohamed IN. Pharmacological and non-pharmacological management of spinocerebellar ataxia: a systematic review. J Neurol. 2022;269(5):2315–37.
Corben LA, Collins V, Milne S, et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. Orphanet J Rare Dis. 2022;17(1):415.
Xiong E, Lynch AE, Corben LA, et al. Health related quality of life in Friedreich ataxia in a large heterogeneous cohort. J Neurol Sci. 2020;410:116642.
Wilson CL, Fahey MC, Corben LA, et al. Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important? Eur J Neurol. 2007;14(9):1040–7.
Graves TD, Cha YH, Hahn AF, et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation. Brain. 2014;137(Pt 4):1009–18.
Santos LR, Teive HAG, Lopes Neto FDN, Macedo ACB, Mello NM, Zonta MB. Quality of life in individuals with spinocerebellar ataxia type 10: a preliminary study. Arq Neuropsiquiatr. 2018;76(8):527–33.
Kedar S, Ghate D, Murray EL, Corbett JJ, Subramony SH. Vision related quality of life in spinocerebellar ataxia. J Neurol Sci. 2015;358(1–2):404–8.
van Os NJH. Quality of life in ataxia-telangiectasia. Eur J Paediatr Neurol. 2022;40:A1.
Rönnefarth M, Hanisch N, Brandt AU, et al. Dysphagia affecting quality of life in cerebellar ataxia-a large survey. Cerebellum. 2020;19(3):437–45.
Buesch K, Zhang R. A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia. Curr Med Res Opin. 2022;38(10):1739–49.
Bolzan G, Leotti VB, de Oliveira CM, et al. Quality of life since pre-ataxic phases of spinocerebellar ataxia type 3/Machado-Joseph disease. Cerebellum. 2022;21(2):297–305.
McGlashan HL, Blanchard CV, Luscombe C, et al. Quality of life and neurological disability in children and young people with ataxia telangiectasia. Eur J Paediatr Neurol. 2022;40:34–9.
Thordarson D, Silva J, Ouyang B, Bernard B, Hall D. Quality of life in fragile X-associated tremor/ataxia syndrome. Mov Disord Clin Pract. 2022;9(5):710–1.
Diaféria G, Bommarito S, Braga Neto P, et al. Effect of speech therapy on quality of life in patients with spinocerebelar ataxia type 3. Arq Neuropsiquiatr. 2022;80(10):1017–25.
Pérez-Flores J, Hernández-Torres A, Montón F, Nieto A. Health-related quality of life and depressive symptoms in Friedreich ataxia. Qual Life Res. 2020;29(2):413–20.
Kelly MJ, Bogdanova-Mihaylova P, Skeens J, et al. The Cost of Living with Inherited Ataxia in Ireland. Cerebellum. 2022;21(2):280–96.
Reilly_Associates. Work productivity and activity impairment questionnaire: General Health V2.0 (WPAI:GH). http://www.reillyassociates.net/WPAI_GH.html. Published 2004. Accessed 19 February, 2023.
Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
Blake C, Codd MB, O’Meara YM. The Short Form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci. 2000;169(3):195–200.
Motl RW, Baird JF. Health-related quality of life and physical activity in older adults with multiple sclerosis. Int J MS Care. 2023;25(1):26–9.
Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Kurtis MM. Impact of Pharmacotherapy on quality of life in patients with Parkinson’s disease. CNS Drugs. 2015;29(5):397–413.
Gorcenco S, Karremo C, Puschmann A. Patients' perspective in hereditary ataxia. Cerebellum. 2022.
Abele M, Klockgether T. Health-related quality of life in sporadic adult-onset ataxia. Mov Disord. 2007;22(3):348–52.
Schmitz-Hübsch T, Coudert M, Giunti P, et al. Self-rated health status in spinocerebellar ataxia–results from a European multicenter study. Mov Disord. 2010;25(5):587–95.
McGlashan HL, Blanchard CV, Luscombe C, et al. Quality of life and neurological disability in children and young people with ataxia telangiectasia. Eur J Paediatr Neurol. 2022;40:34–9.
Ejaz R, Chen S, Isaacs CJ, et al. Impact of mobility device use on quality of life in children with Friedreich ataxia. J Child Neurol. 2018;33(6):397–404.
Cholewa J, Gorzkowska A, Nawrocka A, Cholewa J. Quality of life of people with Parkinson’s disease in the context of professional work and physiotherapy. Med Pr. 2017;68(6):725–34.
Ophey A, Eggers C, Dano R, Timmermann L, Kalbe E. Health-related quality of life subdomains in patients with Parkinson’s disease: the role of gender. Parkinsons Dis. 2018;2018:6532320.
Joyce MR, Nadkarni PA, Kronemer SI, et al. Quality of life changes following the onset of cerebellar ataxia: symptoms and concerns self-reported by ataxia patients and informants. Cerebellum. 2022;21(4):592–605.
Acknowledgements
We would like to thank Ataxia Ireland and all participants involved in this study. We would like to thank Aravind Jayadev Menon for assistance with statistical analysis of the data.
Author information
Authors and Affiliations
Contributions
PJM was involved in the analysis and interpretation of the data and drafting of the manuscript. PBM, RW and SMM were involved in the conception and acquisition of data and in revising of the manuscript. TXY was involved in the acquisition and analysis of the data. SM was involved in the acquisition of the data. All authors agree to be accountable for all aspects of this work and have approved the final version to be published.
Corresponding author
Ethics declarations
Ethics Approval
This study was granted ethical approval by the SJH/AMNCH Research Ethics Committee.
Consent to Participate
Completion of the survey anonymously was taken as implied consent to participate.
Competing Interests
The authors declare no financial or other conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Richard A. Walsh, Sinéad M. Murphy, and Petya Bogdanova-Mihaylova are members of the European Reference Network for Rare Neurological Diseases (Project ID No 739510).
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Menon, P.J., Yi, T.X., Moran, S. et al. Health-Related Quality of Life in Patients with Inherited Ataxia in Ireland. Cerebellum (2023). https://doi.org/10.1007/s12311-023-01640-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s12311-023-01640-3